Geneva, April 27 -- International Clinical Trials Registry received information related to the study (NCT07531628) titled 'A Study to Test How Verducatib is Taken up in the Body of Healthy Chinese Participants' on April 9.
Study Type: Interventional
Study Design:
Allocation: N/A. Intervention model: Single Group Assignment. Primary purpose: Treatment. Masking: None (Open Label).
Primary Sponsor: Boehringer Ingelheim
Condition:
Healthy
Intervention:
Drug: Verducatib
Recruitment Status: Not recruiting
Phase: Phase 1
Date of First Enrollment: July 13, 2026
Target Sample Size: 12
Countries of Recruitment:
China
To know more, visit https://clinicaltrials.gov/study/NCT07531628
Published by HT Digital Content Services with per...